Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contrast-Enhanced Ultrasound for Biopsy Site Selection in Transplant Kidneys
NCT02625428Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- Nov 2015
- Primary completion
- Dec 2018
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of perflutren lipid microspheres in kidney transplant rejection (2 arms), sponsored by Mayo Clinic. Primary endpoint: Abnormal Biopsy at 1 year. Started Nov 2015; status: completed.
02
Drugs
perflutren lipid microspheres
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT02625428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02625428.